Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9321905 | 0.88 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL13950019 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL110870 | 0.82 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL5576921 | 0.82 | THRB (0.50) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL1104076 | 0.82 | THRB (0.47) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL14712313 | 0.82 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL278238 | 0.81 | THRB (0.46) | THRBTSHRALDH1A1TDP1POLB | |
| Hydrochloric Acid SCHEMBL23116684 | 0.81 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| Bromide SCHEMBL7193814 | 0.81 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL11222545 | 0.81 | THRB (0.48) | THRBTSHRALDH1A1TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111107841-B | Method for preparing solid dosage forms comprising antibodies by wet granulation, extrusion and spheronization | 蒂洛特斯制药股份有限公司 | 2023-03-10 | — | — | CN | claimed |